eBioMedicine – The Lancet Discovery Science (@ebiomedicine) 's Twitter Profile
eBioMedicine – The Lancet Discovery Science

@ebiomedicine

Leading biomedical #openaccess journal, bridging the gap between basic and clinical research. Part of @TheLancet Discovery Science. IF=9.7 #Lancet200

ID: 2550149892

linkhttps://www.thelancet.com/journals/ebiom/home calendar_today06-06-2014 14:26:35

4,4K Tweet

10,10K Takipçi

2,2K Takip Edilen

eBioMedicine – The Lancet Discovery Science (@ebiomedicine) 's Twitter Profile Photo
eBioMedicine – The Lancet Discovery Science
@ebiomedicine

4 months ago

Editor pick from May issue Dr. Li & coll Report that PARP inhibitors effectively inhibit PAR synthesis at centrosomes and cause senescence of tumour cells by abrogating the correction of mitotic extra-pole error. Read bit.ly/3UPzcoR

Editor pick from May issue Dr. Li & coll Report that PARP inhibitors effectively inhibit PAR synthesis at centrosomes and cause senescence of tumour cells by abrogating the correction of mitotic extra-pole error. Read bit.ly/3UPzcoR